Humanigen Inc (fka HGENQ)

[cowtown jay]

Speaking of interesting clinical trial correlations, here's another reporting similar progress.

U.S. FDA Approves Label Update for Kite’s Yescarta® CAR T-Cell Therapy to Include Overall Survival Data
December 21, 2023

https://www.businesswire.com/news/home/20231220595740/en/U.S.-FDA-Approves-Label-Update-for-Kite%E2%80%99s-Yescarta%C2%AE-CAR-T-Cell-Therapy-to-Include-Overall-Survival-Data

When it comes to Yescarta/Tecartus, and the Zuma trials with the different suffixes, I'm totally lost.

We had this from Zuma-19:

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma

NOVEMBER 15, 2022

https://ashpublications.org/blood/article/140/Supplement%201/10318/489550/ZUMA-19-A-Phase-1-2-Study-of-Axicabtagene

So despite not having a conclusion that I can draw, since I think we pulled out of one of the Zuma trials, I mention this news regarding the FDA approval of the label update, just in case it sheds light on how this treatment progress is being made.

I'd like to know if there are alternative therapies achieving similar results to lenz.